title: [Changes in gene expression in the course of proliferative processes in the parathyroid gland].
abstract: The aim of this study was to investigate the changes in expression pattern of the most important genes connected with apoptosis in proliferative apoptotic lesions (hyperplasia, adenoma), applying cDNA microarray technique, in order to promote the possible diagnostic or therapeutic utilisation of any difference in gene expression compared to the healthy (normal) parathyroid gland. Samples were taken from surgically removed 2 hyperplasias, 2 adenomas and 2 normal parathyroid glands. The Apoptosis Gene Array (Superarray) was used. This contains 112 genes, in tetraspot arrangement. The probes measured 250-600 base pairs. Streptavidin was bound to the array. CDP Star TM chemiluminescent substrate was used for detection. The samples deriving from hyperplasia or adenoma were compared to samples from normal parathyroid glands. The following genes were overexpressed in both hyperplasia and adenoma: CHEK1, ATM, BCL-XL, FAS, TNF, cIAP1, TRAIL, FADD, CASP 4,5,6,8, CD120b, CD137, LTA, TANK, TARF2, CAD, LIGHTR, DR3LG. CASP1,10, BFAR, BOD, BCL2L2, TRANCE were underexpressed in both hyperplasia and adenoma. Genes overexpressed only in hyperplasia were: MDM2, MCL1, BCL2A1, BLK, RIPK2, CD40LG, TRAF5, HUS1, BNIP3. Underexpressed only in hyperplasia: BOK, CIDEA, TRAF1, TRIP. Overexpressed only in adenoma: APOLLON, RIPK1, LTB, LTBR, CASP2,13, cIAP2, CIDEB. Underexpressed only in adenoma: TRAF4 and FASLG. Overexpresion or underexpression meant 1.5-fold difference from normal average values. As a result of this study, both pro-apoptotic and antiapoptotic genes were identified in hyperplasia and adenoma of the parathyroid gland. It seems that increased proliferation is connected also with increased apoptotic activity, but tumor cell candidates are able to survive, by activation of signal pathways resulting in overexpresion of anti-apoptotic genes.
authors.affiliation: I. Patológiai és Kísérleti Rákkutató Intézet, Semmelweis Egyetem, Budapest, Hungary. bszende@korb1.sote.hu
authors.forename: Béla
authors.initials: B
authors.lastname: Szende
authors.forename: Kristóf
authors.initials: K
authors.lastname: Arvai
authors.forename: István
authors.initials: I
authors.lastname: Peták
authors.forename: Katalin
authors.initials: K
authors.lastname: Nagy
authors.forename: Gyula
authors.initials: G
authors.lastname: Végsô
authors.forename: Ferenc
authors.initials: F
authors.lastname: Perner
mesh_terms: D000236:Adenoma / Q000235:genetics*; D017209:Apoptosis / Q000235:genetics*; D049109:Cell Proliferation; D018076:DNA, Complementary; D015536:Down-Regulation; D015870:Gene Expression; D020869:Gene Expression Profiling; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D006965:Hyperplasia / Q000235:genetics; D007202:Indicators and Reagents; D049449:Luminescence; D020411:Oligonucleotide Array Sequence Analysis; D010280:Parathyroid Glands / Q000378:metabolism* / Q000473:pathology; D010282:Parathyroid Neoplasms / Q000235:genetics*; D019809:Streptavidin; D015854:Up-Regulation
chemical_list: D018076:DNA, Complementary; D007202:Indicators and Reagents; D019809:Streptavidin